HIV-1 viral DNA load in peripheral blood mononuclear cells from seroconverters and long-term infected individualsJURRIAANS, S; DEKKER, J. T; DE RONDE, A et al.AIDS (London). 1992, Vol 6, Num 7, pp 635-641, issn 0269-9370Article

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyPRINS, J. M; JURRIAANS, S; DE WOLF, F et al.AIDS (London). 1999, Vol 13, Num 17, pp 2405-2410, issn 0269-9370Article

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyREIJERS, M. H. E; WEVERLING, G. J; SCHUITEMAKER, H et al.Lancet (British edition). 1998, Vol 352, Num 9123, pp 185-190, issn 0140-6736Article

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudineGISOLF, E. H; ENTING, R. H; JURRIAANS, S et al.AIDS (London). 2000, Vol 14, Num 11, pp 1583-1589, issn 0269-9370Article

Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogsDE JONG, J. J; GOUDSMIT, J; LUKASHOV, V. V et al.AIDS (London). 1999, Vol 13, Num 1, pp 75-80, issn 0269-9370Article

Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivoJURRIAANS, S; DE RONDE, A; DEKKER, J et al.Journal of medical virology. 1995, Vol 45, Num 1, pp 91-98, issn 0146-6615Article

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavirVAN PRAAG, R. M. E; WEVERLING, G. J; PRINS, J. M et al.AIDS (London). 2000, Vol 14, Num 9, pp 1187-1194, issn 0269-9370Article

Anlaysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individualsJURRIAANS, S; DE RONDE, A; DEKKER, J et al.Journal of general virology. 1992, Vol 73, pp 1537-1541, issn 0022-1317, 6Article

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4 + T cell depletionVAN PRAAG, R. M. E; PRINS, J. M; FOX, C. H et al.Journal of clinical immunology. 2001, Vol 21, Num 3, pp 218-226, issn 0271-9142Article

The effect of treatment intensification in HIV-infection : A study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudineGISOLF, E. H; JURRIAANS, S; PELGROM, J et al.AIDS (London). 2000, Vol 14, Num 4, pp 405-413, issn 0269-9370Article

In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitroMAAS, J. J; ROOS, M. T. L; KEET, I. P. M et al.The Journal of infectious diseases. 1998, Vol 178, Num 4, pp 1024-1029, issn 0022-1899Article

A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probesVAN GEMEN, B; VAN BEUNINGEN, R; NABBE, A et al.Journal of virological methods. 1994, Vol 49, Num 2, pp 157-167, issn 0166-0934Article

Inhibition of HIV-1 infectivity by phosphate-methylated DNA : retractionMOODY, H. M; QUAEDFLIEG, P. J. L. M; KOOLE, L. H et al.Science (Washington, D.C.). 1990, Vol 250, Num 4977, pp 125-126, issn 0036-8075, 2 p.Article

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapyWEVERLING, G. J; LANGE, J. M. A; GOUDSMIT, J et al.AIDS (London). 1998, Vol 12, Num 11, pp F117-F122, issn 0269-9370Article

An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudineFOUDRAINE, N. A; DE JONG, J. J; LANGE, J. M. A et al.AIDS (London). 1998, Vol 12, Num 12, pp 1513-1519, issn 0269-9370Article

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineNOTERMANS, D. W; JURRIAANS, S; GOODWIN, C et al.AIDS (London). 1998, Vol 12, Num 2, pp 167-173, issn 0269-9370Article

Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDSJURRIAANS, S; WEVERLING, G. J; GOUDSMIT, J et al.AIDS research and human retroviruses. 1995, Vol 11, Num 4, pp 473-479, issn 0889-2229Article

Safety, pharmacokinetics, and antiviral activity of A77003, a C₂ symmetry-based human immunodeficiency virus protease inhibitorREEDIJ, M; BOUCHER, C. A. B; LEONARD, J. M et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 7, pp 1559-1564, issn 0066-4804Article

Diversity in residual alanine glyosylate aminotransferase activity in hyperoxaluria type I: correlation with pyridoxine responsivenessWANDERS, R. J. A; VAN ROERMUND, C. W. T; REITSMA, W et al.Journal of inherited metabolic disease. 1988, Vol 11, pp 208-211, issn 0141-8955, suppl. 2Article

Semen parameters of a semen donor before and after infection with human immunodeficiency virus type 1: Case reportVAN LEEUWEN, E; CORNELISSEN, M; DE VRIES, J. W et al.Human reproduction (Oxford. Print). 2004, Vol 19, Num 12, pp 2845-2848, issn 0268-1161, 4 p.Article

Evaluation of the World Health Organization staging system for HIV infection and disease in ethiopia : Association between clinical stages and laboratory markersKASSA, E; DE WIT, T. F. R; FONTANET, A. L et al.AIDS (London). 1999, Vol 13, Num 3, pp 381-389, issn 0269-9370Article

Outcome and predictors of failure of highly active antiretroviral therapy : One-year follow-up of a cohort of human immunodeficiency virus type 1-infected personsWIT, F. W. N. M; VAN LEEUWEN, R; DE WOLF, F et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 790-798, issn 0022-1899Article

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapyHOETELMANS, R. M. W; REIJERS, M. H. E; SCHUITEMAKER, H et al.AIDS (London). 1998, Vol 12, Num 11, pp F111-F115, issn 0269-9370Article

Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplificationVAN GEMEN, B; KIEVITS, T; NARA, P et al.AIDS (London). 1993, Vol 7, pp S107-S110, issn 0269-9370, SUP2Conference Paper

Human liver L-alanine-glyoxylate aminotransferase : characteristics and activity in controls and hyperoxaluria type I patients using a simple spectrophotometric methodWANDERS, R. J. A; RUITER, J; VAN ROERMUND, C. W. T et al.Clinica chimica acta. 1990, Vol 189, Num 2, pp 139-144, issn 0009-8981, 6 p.Article